Outlook Therapeutics, Inc. Uncategorized Contracts & Agreements
35 Contracts & Agreements
- Form of Support Agreement (Filed With SEC on January 24, 2024)
- Description of Registrants securities (Filed With SEC on December 22, 2023)
- At-the-market-sales agreement between the Company and BTIG, LLC dated May 16, 2023 (Filed With SEC on May 16, 2023)
- Description of Registrants securities (Filed With SEC on December 29, 2022)
- Letter Agreement, dated December 22, 2022, by and between the Company and M.S. Howells & Co (Filed With SEC on December 23, 2022)
- At The Market Offering Agreement between the Company and H.C. Wainwright & Co. dated March 26, 2021 (Filed With SEC on March 26, 2021)
- Form of Underwriter Warrants (Filed With SEC on February 2, 2021)
- Description of Registrants securities (Filed With SEC on December 23, 2020)
- Engagement Letter, dated June 2, 2020, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on June 23, 2020)
- Engagement letter dated December 10, 2019 by and between the Company and H.C. Wainwright & Co. LLC (Filed With SEC on February 24, 2020)
- Global Amendment, dated as of January 29, 2020 (Filed With SEC on January 31, 2020)
- Agreement to Amend Series A-1 Convertible Preferred between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020 (Filed With SEC on January 31, 2020)
- Amendment dated March 4, 2019 of Strategic Partnership Agreement between the Registrant and MTTR LLC effective as of February 15, 2018, as amended (Filed With SEC on December 19, 2019)
- Amendment dated June 4, 2019 of Strategic Partnership Agreement between the Company and MTTR LLC effective as of February 15, 2018, as amended (Filed With SEC on June 10, 2019)
- Strategic Partnership Agreement by and between the Registrant and MTTR, LLC, effective as of February 15, 2018, as amended by the Letter Addendum dated March 2, 2018 (Filed With SEC on December 18, 2018)
- Lock-up Agreement by and among Oncobiologics, Inc., the Investor named therein and Pankaj Mohan, Ph.D., dated September 7, 2017 (Filed With SEC on September 11, 2017)
- securityagreement (Filed With SEC on December 23, 2016)
- SECURITIES PURCHASEAGREEMENT (Filed With SEC on May 19, 2016)
- ONCOBIOLOGICS, INC. (Filed With SEC on May 11, 2016)
- EXECUTIVEEmployment Agreement (Filed With SEC on April 27, 2016)
- EXECUTIVEEmployment Agreement (Filed With SEC on April 27, 2016)
- EXECUTIVEEmployment Agreement (Filed With SEC on April 27, 2016)
- EXECUTIVEEmployment Agreement (Filed With SEC on April 27, 2016)
- CONFIDENTIAL (Filed With SEC on February 26, 2016)
- L E AS E A G R E E M E N T (Filed With SEC on January 15, 2016)
- L E A S E A G R E E M E N T (Filed With SEC on January 15, 2016)
- JointParticipation Agreement ByAnd Between Oncobiologics,Inc. And ZhejiangHuahai Pharmaceutical Co., Ltd. Effectiveas of May 6 , 2013 (Filed With SEC on January 15, 2016)
- CONFIDENTIAL (Filed With SEC on January 15, 2016)
- IndemnityAgreement (Filed With SEC on January 15, 2016)
- Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512 (Filed With SEC on January 15, 2016)
- Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512 (Filed With SEC on January 15, 2016)
- Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512 (Filed With SEC on January 15, 2016)
- Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512 (Filed With SEC on January 15, 2016)
- Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512 (Filed With SEC on January 15, 2016)
- EMPLOYMENTAGREEMENT (Filed With SEC on January 15, 2016)
